Ophthalmic composition containing xanthan gum and amino acid

Details Ophthalmic composition containing xanthan gum and amino acid Ophthalmic composition containing xanthan gum and amino acid

2011-05-10

2011-05-10

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S561000

Reexamination Certificate

active

07939511

ABSTRACT:
The present invention provides an ophthalmic composition containing xanthan gum, or xanthan gum and an amino acid, which has a superior corneal epithelial disorder-treating effect and a superior corneal epithelial cell-protecting effect.

REFERENCES:
patent: 4136177 (1979-01-01), Lin et al.
patent: 5013714 (1991-05-01), Lindstrom et al.
patent: 5571503 (1996-11-01), Mausner
patent: 5846950 (1998-12-01), Fedorov et al.
patent: 2002/0035088 (2002-03-01), Perdiguer et al.
patent: 2003/0068250 (2003-04-01), Huth et al.
patent: 2004/0034042 (2004-02-01), Tsuji et al.
patent: 2005/0136391 (2005-06-01), Steinhardt
patent: 1085081 (1994-01-01), None
patent: 0 136 782 (1985-04-01), None
patent: 0 778 021 (1997-06-01), None
patent: 0 799 615 (1997-10-01), None
patent: 1358883 (2003-11-01), None
patent: 06-25005 (1994-02-01), None
patent: 08-291060 (1996-11-01), None
patent: 10-109934 (1998-04-01), None
patent: 11-279194 (1999-10-01), None
patent: 2001-508035 (2001-06-01), None
patent: 2001-253822 (2001-09-01), None
patent: 2001-516713 (2001-10-01), None
patent: 2002-20279 (2002-01-01), None
patent: 2002-501017 (2002-01-01), None
patent: 2002-501533 (2002-01-01), None
patent: 2002-506461 (2002-02-01), None
patent: 2002-510654 (2002-04-01), None
patent: 2002-521332 (2002-07-01), None
patent: 2002-521333 (2002-07-01), None
patent: 2003-128553 (2003-05-01), None
patent: 2003-137781 (2003-05-01), None
patent: 2004-59432 (2004-02-01), None
patent: 2004-203836 (2004-07-01), None
patent: 2005-53905 (2005-03-01), None
patent: 2005-60279 (2005-03-01), None
patent: 2 056 821 (1996-03-01), None
patent: 2 198 633 (2003-02-01), None
patent: 93/23017 (1993-11-01), None
patent: 98/17249 (1998-04-01), None
patent: 98/53809 (1998-12-01), None
patent: 99/00133 (1999-01-01), None
patent: 99/13863 (1999-03-01), None
patent: 99/37292 (1999-07-01), None
patent: 99/51273 (1999-10-01), None
patent: 00/04899 (2000-02-01), None
patent: WO 0249611 (2002-06-01), None
patent: 03/092706 (2003-11-01), None
Santvliet et al. Eur. J. Pharm. Sci., 1999, 7, p. 339-345.
English machine translation of Japanese Patent Document JP 2004-203836, http://dossier1.ipdl.inpit.go.jp/, accessed online on Jun. 14, 2010.
Letter dated Jun. 29, 2009 from China Science Patent and Trademark Agent LTD. showing receipt of Office Action issued Jun. 5, 2009 from the Chinese Patent Office with translation of text portion of the Office Action.
L. Romanelli et al., “Ocular Absorption and Distribution of Bendazac After Topical Administration to Rabbits with Different Vehicles”, Life Sciences, vol. 54, No. 13, Jan. 1, 1994, pp. 877-885.
Database WPI Week 200239 Thompson Scientific, AN 2002-355876, XP 002553727, Abstract to JP 2002-20279.
Database WPI Week 199703 Thompson Scientific, AN 1997-029454, XP 002553728, Abstract to JP 08-291060.
Database WPI Week 199651 Thompson Scientific, AN 1996-516743, XP 002553729, Abstract to RU 2056821.
Database WPI Week 199412 Thompson Scientific, AN 1994-094801, XP 002553730, Abstract to JP 06-025005.
Database WPI Week 200369 Thompson Scientific, AN 2003-729221, XP 002553731, Abstract to RU 2 198 633.
Database WPI Week 200367 Thompson Scientific, AN 2003-700800, XP 002553732, Abstract to JP 2003-128553.
Database WPI Week 199954 Thompson Scientific, AN 1999-629280, XP 002553733, Abstract to JP 11-279194.
Database WPI Week 200203 Thompson Scientific, AN 2002-021021, XP 002553734, Abstract to JP 2001-253822.
European Patent Office Office Action issued Jan. 19, 2011 in corresponding European Application No. 05 788 319.1, in the English language.

Affiliated with

Also associated with

Rating

Ophthalmic composition containing xanthan gum and amino acid does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic composition containing xanthan gum and amino acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic composition containing xanthan gum and amino acid will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2675687